Financial Information
Stock Information
Press Release




Subject : [AFP] S. Korea approves sales of new stem cell drug
Register : MEDIPOST
View/Date : Hit : 6926, Date : 2012/01/26 20:31

S. Korea approves sales of new stem cell drug

A South Korean researcher holds Cartistem, an allogeneic stem cell
drug developed by Seoul-based Medipost (AFP/Medipost)

SEOUL — South Korea's government drug agency cleared the way Thursday for commercial sales of what it called the world's first approved medicine using stem cells collected from other people.

Cartistem, developed by Seoul-based Medipost, will help regenerate knee cartilage using stem cells developed from newborns' umbilical cord blood, the Korea Food and Drug Administration said.

"Cartistem is... the world's first approved allogeneic (taken from different individuals of the same species) stem cell drug, that can offer new opportunity for treatment of patients with degenerative arthritis," the administration said in a statement.

Medipost said 27 billion won ($23.8 million) from private investors and government funds had been invested to develop Cartistem since 2001. The drug can be injected into a patient's knees via surgery.

Clinical trials have been under way in the United States since last year, the statement said.

Two of the world's top 10 drugmakers are in talks to seek a worldwide licence to make the drug, a Medipost spokesman told AFP, adding that final trials involving a large number of people would likely begin in the US in 2015.


All article: 76,  Current Page: 1/6
No. Subject Register Date View
76 [Press] Clinical thesis for lung treatment 'Pneumostem'  published .. MEDIPOST 2014/02/10 237
75 [Press] Medipost, designated 'Stem Cell Hair Growth Solution' resear.. MEDIPOST 2013/12/20 165
74 [Press] Medipost, signed license for 'Cartistem' in India MEDIPOST 2013/12/16 179
73 [Press] Medipost, strengthening marketing of 'Cartistem' by particip.. MEDIPOST 2013/12/09 162
72 [Press] Medipost Lung Treatment Medicine 'Pneumostem' designated Orp.. MEDIPOST 2013/12/05 180
71 [Press] Medipost, core technology of the Alzheimer's dementia treatm.. MEDIPOST 2013/10/24 394
70 [The Korea Times] Medipost recognized as 'investible' stem cell firm MEDIPOST 2013/10/14 1605
69 [Press] Medipost, stem cell dementia treatment 2a clinically approved. MEDIPOST 2013/09/11 461
68 [Press] Medipost 'Cartistem', intensive report on Chicago's WGN-TV MEDIPOST 2013/08/29 378
67 [Press] Medipost, consecutive international patents in dementia trea.. MEDIPOST 2013/08/23 1294
66 [The Korea Times] Medipost paves way for 'stem cell era' MEDIPOST 2013/08/01 847
65 [The Korea Times] Medipost publishes stem cell research MEDIPOST 2013/07/26 495
64 [Press] Mechanism of treatment for cartilage regeneration using stem.. MEDIPOST 2013/07/23 586
63 [Press] 'Neurostem-AD' the treatment for Alzheimer's disease request.. MEDIPOST 2013/06/28 602
62 [The Korea Times] Stem cell scientists look to regain past glory MEDIPOST 2013/06/22 580
1 2 3 4 5 6

18, Seocho-daero 50-gil, Seocho-gu, Seoul, Korea